Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer
Background. Neoadjuvant chemotherapy (NACT) is an important stage in the treatment of patients with breast cancer. Positron emission tomography/computed tomography (PET/СT) with fluorodeoxyglucose labeled with 18F (18F-FDG) is widely used as an effective method of metabolic tumor imaging at the stag...
Saved in:
| Main Authors: | N. G. Chanchikova, E. A. Karlova, A. S. Savelyeva, O. A. Silkina, V. I. Chernov, R. V. Zelchan, O. D. Bragina, A. A. Medvedeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-01-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
POSITRON EMISION TOMOGRAPHY FOR DETECTION OF DISTANT METASTASES IN PATIENTS WITH BREAST CANCER
by: N. G. Chanchikova, et al.
Published: (2020-03-01) -
Efficacy of 18F‐Fluoro‐2‐Deoxyglucose Positron Emission Tomography as a Predictor of Treatment Response to Neoadjuvant S‐1 + Oxaliplatin Chemotherapy for Gastric Cancer
by: Naoki Urakawa, et al.
Published: (2025-04-01) -
To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-04-01) -
Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in prediction of response to neoadjuvant chemotherapy in pediatric osteosarcoma
by: Jehan Ahmed Younis, et al.
Published: (2019-10-01) -
Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy
by: Mark Farrugia, et al.
Published: (2018-10-01)